Fathers’ lifestyle factors could be passed onto their children by epigenetic mechanisms-a finding with public health implications regarding obesity.
Susan K. Murphy, PhD
Researchers studying DNA from umbilical cord blood leukocytes found an association between paternal obesity and hypomethylation at the offspring’s insulin-like growth factor 2 (IGF2) gene.
Study findings indicate that aberrant low methylation at this differentially methylated region is linked to adverse outcomes, including higher risks for certain cancers.1 The research, published in BMC Medicine in 2013, suggests that fathers’ lifestyle factors could be passed onto their children by epigenetic mechanisms-a finding with potential public health implications regarding obesity’s global burden.
“I don’t think that we previously considered that the father could biologically contribute more to his offspring than the DNA in his sperm. Most research has focused on how the in-utero environment and health of the mother would impact development,” says study author Susan K. Murphy, PhD, associate professor in Obstetrics and Gynecology and chief, Division of Reproductive Sciences, Department of Obstetrics and Gynecology, at Duke University Medical Center, Durham, North Carolina. “This research and other emerging data are showing that the preconceptional health of the father, including his body mass index (BMI), are able to impact the status of his child’s DNA. This impact is not due to genetic changes, but rather to epigenetic shifts that determine how the child’s DNA is regulated.”
Murphy and colleagues studied blood leukocytes from 79 newborns’ umbilical cords. They obtained data about parental characteristics with standardized questionnaires and medical records, and they analyzed 2 differentially methylated regions (DMRs): the IGF2 DMR and the DMR upstream of the neighboring H19 gene (H19 DMR).1
They found that about 1 in 5 of the fathers had a BMI of 30 kg/m2 or higher. Although hypomethylation at the IGF2 DMR was linked to paternal obesity, the researchers didn’t find a significant association between paternal obesity and methylation patterns at the H19 DMR.1
The molecular mechanism behind the finding could be a hormonal difference between obese and non–obese parents, the researchers hypothesized.
“As a result, exposures to adverse lifestyle factors or poor or overnutrition during spermatogenesis may affect the reprogramming of methylation profiles at imprinted genes. Further research is necessary to confirm this hypothesis,” the investigators wrote.1
In a comment published in the same BMC Medicine issue called “Fat dads must not be blamed for their children’s health problems,” the authors noted the importance of taking an unbiased look at the big picture-considering the whole genome/epigenome/metabolome and involving all key genes and networks.2
“It is also important to critically assess environmental players,” the comment authors wrote. “It is tempting to overemphasize the role of a small number of parent-of-origin expressing genes and to speculate about the effects of modest variation in methylation, but we must not be too hasty to blame either parent for their offspring's health outcomes without being certain that these effects are consequentially robust.”2
Putting knowledge to practice
Pediatricians and other providers can use epigenetic data like that in BMC Medicine to help fathers understand that the way they take care of themselves and decisions they make might impact the health of even their unborn children, according to Murphy.
“As we learn more about the impact of the father’s health status and environmental exposures on the offspring’s epigenetic profile and how this might affect health outcomes, it is important for couples thinking about a future pregnancy to take into account that the health of the dad’s sperm might not be optimal if he is not in good overall health or is exposed to environmental toxicants (pesticides, smoking tobacco, alcohol use, etc.). Optimizing dad’s health and minimizing his exposures will likely increase the chances of a healthy epigenetic outcome for his future children,” Murphy says.
What about paternal cannabis use?
Murphy was among the authors of a recent pilot study of men who use cannabis alongside a study in rats exposed to delta-9-tetrohydrocannabinol (THC), the major psychoactive component in cannabis. That pilot study was published in December 2018 in the journal Epigenetics.3
“We found that the sperm of the cannabis users and the THC-exposed male rats had epigenetic profiles that were substantially altered,” Murphy says. “The particular genes that were affected were those involved in early growth and development, and also genes that become deregulated in cancers. However, we do not yet know if these epigenetic changes are able to be transmitted to the offspring, or if the changes are temporary or permanent in terms of sperm production. We are currently expanding this study and trying to answer these questions.”
Murphy and her coauthors have found that offspring of the male THC-exposed rats show behavioral changes. Those findings are presented in a new study published in April 2019 in Neurotoxicology and Teratology.4
“Again, this speaks to the idea that to be abundantly cautious, it would be best for couples planning pregnancy to abstain from cannabis use,” Murphy says.
1. Soubry A, Schildkraut JM, Murtha A, et al. Paternal obesity is associated with IGF2 hypomethylation in newborns: results from a Newborn Epigenetics Study (NEST) cohort. BMC Med. 2013;11:29.
2. Moore GE, Stanier P. Fat dads must not be blamed for their children's health problems. BMC Med. 2013;11:30.
3. Murphy SK, Itchon-Ramos N, Visco Z, et al. Cannabinoid exposure and altered DNA methylation in rat and human sperm. Epigenetics. 2018;13(12):1208-1221.
4. Levin ED, Hawkey AB, Hall BJ, et al. Paternal THC exposure in rats causes long-lasting neurobehavioral effects in the offspring. Neurotoxicol Teratol. April 24, 2019. Epub ahead of print.
Overcoming pediatric obesity: Behavioral strategies and GLP-1 support
October 4th 2024Kay Rhee, MD, discusses the challenges of pediatric obesity treatment, highlighting the role of biological and environmental factors, behavioral interventions, and the potential benefits of GLP-1 medications in weight management for children and teens.